Hubei Goto Biopharm: Announcement of Resolution of the 25th Meeting of the Second Board of Directors.
Hubei Goto Biopharm: Announcement on the Progress of Providing Guarantees for Applying for Comprehensive Credit Lines for Subsidiaries.
Hubei Goto Biopharm: Announcement of Resolutions of the 24th Meeting of the 2nd Board of Directors
Hubei Goto Biopharm: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Hubei Kyodo Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: CITIC Securities Co., Ltd.'s 2023 follow-up report on Hubei Kyodo Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: CITIC Securities Co., Ltd. on the inspection results of Hubei Kyodo Pharmaceutical Co., Ltd.'s 2023 continuous supervision work site inspection results and reminders to the company
Hubei Goto Biopharm: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Hubei
Hubei Goto Biopharm: Kyodo Pharmaceutical Investor Relations Activity Record Form May 10, 2024
Hubei Goto Biopharm: Kyodo Pharmaceutical Investor Activity Record Form for May 9, 2024
Hubei Goto Biopharm: Announcement on holding the 2023 Annual Results Briefing
Hubei Goto Biopharm: Announcement of Resolutions of the 23rd Meeting of the Second Board of Directors
Hubei Goto Biopharm: CITIC Securities Co., Ltd.'s inspection opinion on the daily related transactions expected by Hubei Kyodo Pharmaceutical Co., Ltd. in 2024
Hubei Goto Biopharm: 2023 Independent Director Debriefing Report (Yang Jian)
Hubei Goto Biopharm: Special report on the storage and use of funds raised in 2023
Hubei Goto Biopharm: 2023 Board Work Report
Hubei Goto Biopharm: 2023 Independent Director Debriefing Report (Xia Chengcai)
Hubei Goto Biopharm: 2023 Independent Director Debriefing Report (Ji Jiansheng)
Hubei Goto Biopharm: Verification Opinions of CITIC Securities Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Hubei Kyodo Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: The Board's special opinion on the sole director's independence assessment
Hubei Goto Biopharm: 2023 Social Responsibility Report
No Data